Tina Loeffler

Grambach, 8074, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Network pharmacology-based discovery and experimental validation of novel drug repurposing candidates in Alzheimer's Disease.

Network pharmacology-based discovery and experimental validation of novel drug repurposing candidates in Alzheimer's Disease.

Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026

Longitudinal progression of blood biomarkers reveals a key role of reactive astrocytosis in preclinical Alzheimer's disease.

Longitudinal progression of blood biomarkers reveals a key role of reactive astrocytosis in preclinical Alzheimer's disease.

Journal: Med (New York, N.Y.)
Published: September 10, 2024

Motor deficits and brain pathology in the Parkinson's disease mouse model hA53Ttg.

Motor deficits and brain pathology in the Parkinson's disease mouse model hA53Ttg.

Journal: Frontiers in neuroscience
Published: July 09, 2024

Corrigendum to "Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice" [MOLMET 85 (2024) 1-16].

Corrigendum to "Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice" [MOLMET 85 (2024) 1-16].

Journal: Molecular metabolism
Published: June 26, 2024

Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice.

Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice.

Journal: Molecular metabolism
Published: February 19, 2024

Longitudinal progression of blood biomarkers reveals a key role of astrocyte reactivity in preclinical Alzheimer's disease.

Longitudinal progression of blood biomarkers reveals a key role of astrocyte reactivity in preclinical Alzheimer's disease.

Journal: medRxiv : the preprint server for health sciences
Published: February 12, 2024

Astaxanthin enhances autophagy, amyloid beta clearance and exerts anti-inflammatory effects in in vitro models of Alzheimer's disease-related blood brain barrier dysfunction and inflammation.

Astaxanthin enhances autophagy, amyloid beta clearance and exerts anti-inflammatory effects in in vitro models of Alzheimer's disease-related blood brain barrier dysfunction and inflammation.

Journal: Brain research
Published: May 31, 2023

Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's disease.

Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's disease.

Journal: Molecular psychiatry
Published: April 09, 2022

No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines study.

No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines study.

Journal: Brain communications
Published: January 14, 2022

A brain proteomic signature of incipient Alzheimer's disease in young APOE ε4 carriers identifies novel drug targets.

A brain proteomic signature of incipient Alzheimer's disease in young APOE ε4 carriers identifies novel drug targets.

Journal: Science advances
Published: November 10, 2021

Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer's Disease.

Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD
Published: March 01, 2021

Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein.

Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein.

Journal: Journal of Alzheimer's disease : JAD
Published: February 13, 2021
Showing 1-12 of 24

Last Updated: 09/26/2026